Coadministration of IL-12 or IL-10 expression cassettes drives immune responses toward a Th1 phenotype

Journal of Interferon and Cytokine Research

Volumn 18, Issue 7, 1998, Pages 537-547

  Kim, Jong J ^a,b   Maguire Jr , Henry C ^c   Nottingham, Liesl K ^b   Morrison, Lake D ^b   Tsai, Anthony ^b   Sin, Jeong I ^b   Chalian, Ara A ^b   Weiner, David B ^b,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d Stellar Chance Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTACT ALLERGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; OXAZOLONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; GENE TARGETING; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0031950432     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.537     Document Type: Article

References (47)

1. STASNEY, J., CANTAROW, A., and PASCHKIS, K.E. (1955). Production of neoplasms by injection of fractions of mammalian neoplasms. Cancer Res. 11, 775-782.
2. PASCHKIS, K.E., CANTAROW, A., and STASNEY, J. (1955). Induction of neoplasms by injection of tumor chromatin. J. Natl. Cancer Inst. 15, 1525-1532.
3. ITO, Y. (1960). A tumor-producing factor extracted by phenol from papillomatous tissue of cottontail rabbits. Virology 12, 596-601.
4. KIM, J.J., and WEINER, D.B. (1997). DNA/genetic vaccination for HIV. Springer Semin. Immunopathol. 19, 174-195.
5. CHATTERGOON, M., BOYER, J., and WEINER, D.B. (1997). Genetic immunization: a new era in vaccines and immune therapies. FASEB J. 11, 753-763.
6. KIM, J.J., AYYVOO, V., BAGARAZZI, M.L., CHATTERGOON, M.A., DANG, K., WANG, B., BOYER. J.D., and WEINER, D.B. (1997). In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158, 816-826.
7. BOYER, J.D., UGEN, K.E., WANG, B., AGADJANYAN, M.G., GILBERT, L., BAGARAZZI, M., CHATTERGOON, M., FROST, P., JAVADIAN, A., WILLIAMS, W.V., REFAELI, Y., CICCARELLI, R.B., McCALLUS, D., CONEY, L., and WEINER, D.B. (1997). Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med. 3, 526-532.
8. WANG, B., UGEN, K.E., SRIKANTAN, V., AGADJANYAN, M.G., DANG, K., REFAELI, Y., SATO, A., BOYER, J., WILLIAMS, W.V., and WEINER, D.B. (1993). Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 4156-4160.
9. WANG, B., BOYER, J.D., UGEN, K.E., SRIKANTAN, V., AYYAVOO, V., AGADJANYAN, M.G., WILLIAMS, W.V., NEWMAN, M., CONEY, L., CARRANO, R., and WEINER, D.B. (1995). Nucleic acid-based immunization against HIV-1: induction of protective in vivo immune responses. AIDS 9, S159-170.
10. TANG, D., DeVIT, M., and JOHNSTON, S. (1992). Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154.
11. ULMER, J.B., DONNELLY, J., PARKER, S.E., RHODES, G.H., FELGNER, P.L., DWARKI, V.L., GROMKOWSKI, S.H., DECK, R., DeVITT, C.M., FRIEDMAN, A., HAWE, L.A., LEANDER, K.R., MARINEZ, D., PERRY, H., SHIVER, J.W., MONTGOMERY, D., and LIU, M.A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
12. DAVIS, H., MICHEL, M.L., and WHALEN, R.G. (1993). DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Human Mol. Genet. 2, 1847-1851.
13. FYNAN, E., WEBSTER, R., FULLER, D., HAYNES, J., SANTORO, J., and ROBINSON, H. (1993). DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90, 11478-11482.
14. CONRY, R.M., LoBUGLIO, A.F., KANTOR, J., SCHLOM, J., LOECHEL, F., MOORE, S.E., SUMEREL, L.A., BARLOW, D.L., ABRAMS, S., and CURIEL, D.T. (1994). Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 54, 1164-1168.
15. KIM, J.J., TRIVEDI, N.N., WILSON, D.M., MAHALINGAM, S., MORRISON, L., TSAI, A., CHATTERGOON, M.A., DANG, K., PATEL, M., AHN, L., CHALIAN, A.A., BOYER, J.D., KIEBEREMMONS, T., AGADJANYAN, M.G., and WEINER, D.B. (1998). Molecular and immunological analysis of genetic prostate antigen (PSA) vaccine. Oncogene. In press.
16. MARGOLIS, H.S. (1993). Prevention of acute and chronic liver disease through immunization: hepatitis B and beyond. J. Infect. Dis. 168, 9-14.
17. ZAROZINSKI, C.C., FYNAN, E.F., SELIN, L.K., ROBINSON, H.L., and WELSH, R.M. (1995). Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154, 4010-4017.
18. GANSBACHER, B., ZIER, K., DANIELS, B., CRONIN, K., BANNERJI, R., and GILBOA, E. (1990). Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 4, 1217-1224.
19. GOLUMBEK, P., LAZENBY, A., LEVITSKY, H.I., JAFFEE, E., KARASUYAMA, H., BAKER, M., and PARDOLL, D.M. (1992). Treatment of established renal cancer by tumor cells engineered to secrete interleukin 4. Science 254, 713-716.
20. DRANOFF, G., and MULLIGAN, R.C. (1995). Gene transfer as cancer therapy. Adv. Immunol. 58, 417-454.
21. SUN, W.H., BURKHOLDER, J.K., SUN, J., CULP, J., TURNER, J., LU, X.G., and PUGH, T.D. (1995). In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc. Natl. Acad. Sci. USA 92, 2889-2893.
22. KIM, J.J., TRIVEDI, N.N., NOTTINGHAM, L., MORRISON, L., TSAI, A., HU, Y., MAHALINGAM, S., DANG, K., AHN, L., DOYLE, N.K., WILSON, D.M., CHATTERGOON, M.A., CHALIAN, A.A., BOYER, J.D., AGADJANYAN, M.G., and WEINER, D.B. (1998). Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28, 1089-1103.
23. CALLARD, R., and GEARING, A. (1994). The Cytokine Facts-Book. London: Academic Press Limited.
24. KIM, J.J., BAGARAZZI, M.L., TRIVEDI, N., HU, Y., CHATTERGOON, M.A., DANG, K., MAHALINGAM, S., AGADJANYAN, M.G., BOYER, J.D., WANG, B., and WEINER, D.B. (1997). Engineering of in vivo immune responses to DNA immunization via co-delivery of costimulatory molecule genes. Nature Biol. 15, 641-645.
25. ASHERSON, G.L., and PTAK, W.L. (1969). Contact and delayed hypersensitivity in the mouse. 1. Active sensitization and passive transfer. Immunology 15, 405-416.
26. COFFMAN, R.L., SEYMOUR, B.W.P., LEBMAN, D.A., HIRAKI, D.D., CHRISTIANSEN, J.A., SHRADER, B., CHERWINSKI, H.M., SAVELKOUL, H.F.J., FINKELMAN, F.D., BOND, M.W., and MOSMANN, T.R. (1988). The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102, 5-28.
27. FINKELMAN, F.D., HOLMES, J., KATONA, I.M., URBAN, J.F., BECKMANN, M.P., PARK, L.S., SCHOOLEY, K.A., COFFMAN, R.L., MOSMANN, T.R., and PAUL, W.E. (1990). Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8, 303-333.
28. + T cell clones. J. Immunol. 141, 849-855.
29. MOGENSEN, S.C., and VIRELIZIER, J.L. (1987). The interferon-macrophage alliance [Review]. Interferon 8, 55-84.
30. + T cells. Annu. Rev. Immunol. 12, 635-673.
31. SATO, Y., ROMAN, M., TIGHE, H., LEE, D., CORR, M., NGUYEN, M.D., SILVERMAN, G.J., LOTZ, M., CARSON, D.A., and RAZ, E. (1996). Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354.
32. KLINMAN, D.M., YAMSHCHIKOV, G., and ISHIGATSUBO, Y. (1997). Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158, 3635-3639.
33. TRINCHIERI, G. (1995). Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate persistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
34. ROBERTSON, M.J., SOIFFER, R.J., WOLF, S.F., MANLEY, T.J., DONAHUE, C., YOUNG, D., HERMANN, S.H., and RITZ, J. (1992). Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175, 779-788.
35. GATELY, M.K., WOLITZKY, A.G., QUINN, P.M., and CHIZZONITE, R. (1992). Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143, 127-142.
36. BLOOM, E.T., and HORVATH, J.A. (1994). Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity: implications for the age-related decline in CTL. J. Immunol. 152, 4242-4254.
37. MAGUIRE, H.C.J. (1995). Murine recombinant interleukin-12 increases the acquisition of allergic contact dermatitis in the mouse. Int. Arch. Allergy Immunol. 106, 166-168.
38. FIORENTINO, D.F., BOND, M.W., and MOSMANN, T.R. (1989). Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095.
39. DE WAAL-MALEFYT, R., ABRAMS, J., BENNETT, B., FIGDOR, C.G., and DE VRIES, J. (1991). Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
40. FIORENTINO, D.F., ZLOTNIK, A., MOSMANN, T.R., HOWARD, M., and O'GARRA, A. (1991). IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815.
41. HSU, D.H., MOORE, K.W., and SPITS, H. (1992). Differential effects of interleukin-4 and -10 on interleukin-2 induced interferon-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 4, 563.
42. ENK, A.H., SALOGA, J., BECKER, D., and KNOP, J. (1994). Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 179, 1397-1402.
43. KONDO, S., McKENZIE, R.C., and SAUDER, D.N. (1994). Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J. Invest. Dermatol. 103, 811-814.
44. FERGUSON, T.A., DUBE, P., and GRIFFITH, T.S. (1994). Regulation of contact hypersensitivity by interleukin-10. J. Exp. Med. 179, 1597-1604.
45. GIOVARELLI, M., MUSIANI, P., MODESTI, A., DELLABONA, P., CASORATI, G., ALLIONE, A., CONSALVO, M., CAVALLO, F., DIPIERRO, F., DE GIOVANNI, C., MUSSO, T., and FORNI, G. (1995). Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol. 155, 3112-3123.
46. CLERICI, M., WYNN, T.A., BERZOFSKY, J.A., BLATT, S.P., HENDRIX, C.W., SHER, A., COFFMAN, R.L., and SHEARER, G.M. (1994). Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93, 768-775.
47. AKRIDGE, R.E., OYAFUSO, L.K., and REED, S.G. (1994). IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 153, 5782-5789.